Compare

Arcadia Biosciences, Inc. vs SRX Global Inc. vs Vita Coco Company, Inc. vs Keurig Dr Pepper Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearArcadia Biosciences, Inc.
RKDA
SRX Global Inc.
SRXH
Vita Coco Company, Inc.
COCO
Keurig Dr Pepper Inc.
KDP
Year ended2025-12-312025-09-302025-12-312025-12-31
Revenue$4.86M$6.53M$609.78M$16.60B
Revenue growth (YoY)-3.7%n/a+18.2%+8.2%
Gross margin36.2% (computed)23.4%36.5%54.2%
Operating margin-51.5%-174.6%13.5%21.5%
Net margin-48.1%-688.8%11.7%12.5%
Net income-$2.34M-$45.01M$71.32M$2.08B
EPS (Diluted)-$1.71-$2.13$1.19$1.53
Operating cash flow-$4.74M-$8.14M$47.17M$1.99B
Free cash flow-$4.74Mn/a$39.02M$1.50B
Cash & equivalents$259.0K$1.31M$196.87M$1.03B
Total assets$6.55M$8.40M$461.16M$55.46B
Total liabilities$2.41M$8.00M$129.62M$29.94B
Shareholders' equity$4.14M$407.0K$331.54M$25.52B
Return on year-end equity-56.5%n/m21.5%8.1%
Shares outstanding1.37M24.92M57.08M1.36B

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearArcadia Biosciences, Inc.SRX Global Inc.Vita Coco Company, Inc.Keurig Dr Pepper Inc.
Latest$4.86M
Ended 2025-12-31
$6.53M
Ended 2025-09-30
$609.78M
Ended 2025-12-31
$16.60B
Ended 2025-12-31
1 year earlier$5.04M
Ended 2024-12-31
n/a$516.01M
Ended 2024-12-31
$15.35B
Ended 2024-12-31
2 years earlier$4.45M
Ended 2023-12-31
n/a$493.61M
Ended 2023-12-31
$14.81B
Ended 2023-12-31
3 years earlier$7.42M
Ended 2022-12-31
n/a$427.79M
Ended 2022-12-31
$14.06B
Ended 2022-12-31
4 years earlier$6.78M
Ended 2021-12-31
n/a$379.51M
Ended 2021-12-31
$12.68B
Ended 2021-12-31